Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Operating Margin (2016 - 2025)

Historic Operating Margin for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 32.23%.

  • Iradimed's Operating Margin rose 6400.0% to 32.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.87%, marking a year-over-year increase of 9600.0%. This contributed to the annual value of 29.99% for FY2024, which is 5700.0% down from last year.
  • Latest data reveals that Iradimed reported Operating Margin of 32.23% as of Q3 2025, which was up 6400.0% from 33.26% recorded in Q2 2025.
  • Iradimed's 5-year Operating Margin high stood at 35.78% for Q3 2023, and its period low was 18.8% during Q2 2021.
  • For the 5-year period, Iradimed's Operating Margin averaged around 28.68%, with its median value being 29.57% (2023).
  • Its Operating Margin has fluctuated over the past 5 years, first soared by 619100bps in 2021, then plummeted by -41900bps in 2024.
  • Iradimed's Operating Margin (Quarter) stood at 26.19% in 2021, then increased by 9bps to 28.62% in 2022, then increased by 3bps to 29.57% in 2023, then grew by 1bps to 29.91% in 2024, then grew by 8bps to 32.23% in 2025.
  • Its Operating Margin was 32.23% in Q3 2025, compared to 33.26% in Q2 2025 and 27.84% in Q1 2025.